After Completion of Production … Pfizer’s Corona Vaccine Faces a New Hurdle



[ad_1]

A Chinese company presented a roadmap regarding the formidable and terrifying logistical challenges faced by those seeking to introduce and distribute the Pfizer vaccine, after the first results showed its effectiveness.

This means that countries must build production, storage and transportation networks to ensure that the vaccine reaches the final consumption points safely.

And even though building such networks requires great investment and coordination, the vaccine will only be available to wealthy countries that have the capacity to establish such networks.

The cost of distributing the vaccine is likely to heighten current concerns that richer countries get it first, despite efforts supported by the World Health Organization to secure the vaccine for poor countries.

The Bloomberg report indicated that even wealthy countries that have requested predoses of the Pfizer vaccine, including Japan, the United States, and the United Kingdom, will face significant obstacles in securing vaccine transportation for logistical reasons, such as truck breakdowns, power outages. sick energy or transportation workers. .

“>

For example, Chinese companies that will distribute Pfizer’s Corona vaccine will have to follow a complex and expensive system to transport the vaccine from airport warehouses to refrigerated vehicles and then to vaccination points throughout China.

Once the vaccine reaches vaccination centers, the vaccines must be thawed to minus 70 degrees Celsius and injected within five days, or else it will face harm, according to a Bloomberg Agency report on Wednesday.

And each time, the distribution companies have to follow the same steps when transporting each quantity of vaccine, which is a process that many see as arduous, and the companies will incur a lot of expenses, which will make the price of the vaccine be tall.

A Chinese company presented a roadmap regarding the formidable and terrifying logistical challenges faced by those seeking to introduce and distribute the Pfizer vaccine, after the first results showed its effectiveness.

This means that countries must build production, storage and transportation networks to ensure that the vaccine reaches the final consumption points safely.

And even though building such networks requires great investment and coordination, the vaccine will only be available to wealthy countries that have the capacity to establish such networks.

The cost of distributing the vaccine is likely to heighten current concerns that richer countries get it first, despite efforts supported by the World Health Organization to secure the vaccine for poor countries.

The Bloomberg report indicated that even wealthy countries that have requested predoses of the Pfizer vaccine, including Japan, the United States, and the United Kingdom, will face significant obstacles in securing vaccine transportation for logistical reasons, such as truck breakdowns, power outages. sick energy or transportation workers. .



[ad_2]